Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Thiabendazole Antikörper

Der Schaf Polyklonal anti-Thiabendazole Antikörper (ABIN487924) detektiert spezifisch Thiabendazole in EIA. Dieser Antikörper reagiert spezifisch mit Proben aus Chemical.
Produktnummer ABIN487924
1.510,77 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für Thiabendazole Antikörper (ABIN487924)

Target

Thiabendazole

Reaktivität

  • 1
  • 1
Chemical

Wirt

  • 2
Schaf

Klonalität

  • 2
Polyklonal

Konjugat

  • 2
Unkonjugiert

Applikation

  • 2
  • 1
  • 1
Enzyme Immunoassay (EIA)
  • Aufreinigung

    Ig Fraction

    Immunogen

    Thiabendazole (5)-BTG

    Isotyp

    IgG
  • Applikationshinweise

    ELISA: 5.0 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    7.36 mg/mL (U.V.abs at 280nm)

    Buffer

    20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2, 0.09 % Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    -20 °C
  • Target

    Thiabendazole

    Substanzklasse

    Chemical

    Hintergrund

    Anthelmintics or anti-helminthics are a class of drugs that are effective against a range of intestinal parasitic worms (helminths). Parasitic helminths must maintain an appropriate feeding site. Nematodes and trematodes must actively ingest and move food through their digestive tracts to maintain an appropriate energy state, these together with reproductive processes require a well defined and developed neuromuscular coordination. Anthelmintic treatment is a multi-targeting system designed to interfere with the integrity of parasite cells. The pharmacologic basis of the treatment for helminths involves the targeting of neuromuscular coordination, or protective mechanisms against host immunity, which lead to starvation, paralysis, and expulsion of the parasite. The benzimidazole class of drugs were introduced in 1961 and interfere with the parasite's ATP pathway on a cellular level. They bind to a specific building block called b-tubulin and prevent its incorporation into certain cellular structures called microtubules, which are essential for energy metabolism.Synonyms: 3-thiazole, 4-(1H-benzimidazol-2-yl)-1, Arbotect, Lombristop, Mintesol, Mintezol, Omnizole, TBZ, Thiabenzole, Thibenzol, Tiabendazole, Tresaderm
Sie sind hier:
Chat with us!